- Report: Pfizer seeks aid of PBMs in efforts to block generic versions of Lipitor
- CVS Caremark names Helena Foulkes EVP, chief healthcare strategy and marketing officer
- Pfizer forms licensing agreement with Seattle Genetics
- Adherence among chronic disease patients can lead to big savings
- Pfizer to sell Lipitor directly by mail
NEW YORK — The chief medical officer at one of the largest drug makers in the world has been named "woman of the year" by the Healthcare Businesswomen's Association.
Freda Lewis-Hall, Pfizer's chief medical officer, will be honored at the HBA's 22nd annual "Woman of the Year" luncheon in May.
Lewis-Hall's 30-year career in healthcare leadership includes roles in direct patient care, academics, media, government, pharmaceuticals and biotechnology.
HBA president Deborah Coogan Seltzer said that Lewis-Hall "sets the tone" for those in the industry for her "long-standing commitment to the social responsibilities of healthcare leadership — especially in making sure that people have the education and understanding to make the best healthcare decisions."